Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:45 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Mild Cognitive Impairment, Mild Alzheimer's Disease
Interventions: PET scan & fMRI; Other
Lead sponsor: Louisiana State University Health Sciences Center Shreveport; Other
Eligibility: 55 Years to 85 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: Shreveport, Louisiana

Conditions: Eldery People, Cognitive Decline, Memory Decline, DHA CNS Delivery
Interventions: LPC-EPA+DHA capsules containing omega-3 fatty acids EPA and DHA esterified to lysophosphatidylcholine (LPC-EPA+DHA)(Trade name: Lysoveta); Dietary Supplement
Lead sponsor: University of Cincinnati; Other
Eligibility: 55 Years to 82 Years
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Mild Cognitive Impairment, Healthy Aging
Interventions: The Computerized Functional Skills Assessment and Training Program, Brain HQ Double Decision; Device
Lead sponsor: i-Function, Inc.; Industry
Eligibility: 60 Years to 100 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Miami, Florida • New York, New York

Conditions: Contact Lens Discomfort, Dry Eye Disease, Meibomian Gland Dysfunction
Interventions: Bruder Moist Heat Compress, Washcloth; Device · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Breast Cancer Survivors, Cognitive Dysfunction
Interventions: Exercise, Control; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 40 Years and older · Female only
Enrollment: 253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Stress, Dementia, Cognitive Impairment
Interventions: Live music therapy, Virtual music therapy; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 65 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Berwyn, Pennsylvania

Conditions: Cognitive Dysfunction, Covid19
Interventions: AKL-T01; Device
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Mild Cognitive Impairment
Interventions: Voice-activated smart speakers; Other
Lead sponsor: Emory University; Other
Eligibility: 55 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Sepsis, Trauma Injury
Interventions: Human feces collection; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 110 Years
Enrollment: 468 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Chronic Granulomatous Disease
Interventions: Nexell Isolex with T-cell Depletion, Baxter isolex 300i; Device
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: Not listed
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Healthy, Vasodilation, Insulin Resistance, Autonomic Dysfunction, Obesity
Interventions: Carbon dioxide breathing, Neurovascular Coupling, Human insulin; Other · Drug
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 45 Years
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Erectile Dysfunction
Interventions: delivery system; Other
Lead sponsor: Pfizer; Industry
Eligibility: 40 Years to 70 Years · Male only
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 2
States / cities: Overland Park, Kansas

Conditions: Mild Cognitive Impairment, Alzheimer Disease
Interventions: Canakinumab, Placebo; Biological · Other
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 45 Years to 90 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Charlestown, Massachusetts • Stony Brook, New York

Conditions: Coronary Microvascular Disease, Ischemic Heart Disease, Myocardial Ischemia
Interventions: Bivalirudin, Adenosine, Heparin, Pressure-Temperature Sensor Guidewire, Guiding Catheter; Drug · Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 125 Years
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2035
U.S. locations: 1
States / cities: New York, New York

Conditions: Cancer Survivor, Cognitive/Functional Effects, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Lymphoma, Psychosocial Effects of Cancer and Its Treatment
Interventions: educational intervention, psychosocial assessment and care; Other · Procedure
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 6 Years to 16 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Duarte, California

Conditions: Low Back Pain, Mechanical, Piriformis Syndrome, Somatic Dysfunction of Sacral Region (Finding)
Interventions: Strain-Counterstrain treatment of piriformis muscle; Other
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Cardiovascular Disease
Interventions: Cardiac MRI; Procedure
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years to 85 Years · Female only
Enrollment: 433 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2051
U.S. locations: 2
States / cities: Los Angeles, California • Gainesville, Florida

Conditions: Alzheimer's Disease
Interventions: KarXT, KarX-EC, Placebo; Drug · Other
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 60 Years to 85 Years
Enrollment: 586 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 31
States / cities: Fullerton, California • Irvine, California • Los Angeles, California + 28 more

Conditions: Cognitive Impairment, Depression
Interventions: PATH-MCI, Supportive Therapy; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 60 Years to 85 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 4
States / cities: Baltimore, Maryland • New York, New York • The Bronx, New York + 1 more

Conditions: Alzheimer's Disease
Interventions: ST101, Placebo; Drug
Lead sponsor: Sonexa Therapeutics, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 15
States / cities: Costa Mesa, California • Redlands, California • San Diego, California + 12 more

Conditions: CTE, TBI (Traumatic Brain Injury)
Interventions: [F-18]FDDNP; Radiation
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 90 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Erectile Dysfunction, Spinal Cord Injuries
Interventions: tadalafil; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Alzheimer Disease
Interventions: Mediterranean Diet, Study Supplement, Low-fat Diet; Behavioral · Dietary Supplement
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 209 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Cognitive Impairment
Interventions: No Intervention, donanemab; Other · Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 60 Years to 90 Years
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 23
States / cities: Phoenix, Arizona • Irvine, California • Bradenton, Florida + 19 more

Search by objective public record fields.

Early Detection of Mild Cognitive Impairment in Individual Patients

Optimizing CNS DHA Delivery in Elderly Adults at Risk for Dementia

A Novel Computer-Based Functional Skills Assessment and Training Program

Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers

Improving Cognition After Cancer

Comparison of Live and Virtual Music-based Interventions in Mitigating Stress

Improving Cognitive Health in COVID-19 Survivors

Voice Technology-Based Self-Management Intervention

Microbiome Dysfunction in Surgical Intensive Care Unit Survivors

Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease

Impact of Intranasal Insulin on Sympathetic Activity and Cerebral Vasodilation

Caverject User Study

Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease

A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction

Educational and Skills Training Program for Parents of Childhood Cancer Survivors Who Have Neurobehavioral Dysfunction

Strain-Counterstrain Treatment of Piriformis Pain

Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Problem Adaptation Therapy for Mild Cognitive Impairment and Depression

Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease

Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy

Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury

Nutrition Interventions for Cognitive Enhancement

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)